Earnings

Novo Nordisk's new chief bets on dealmaking to break free from weight-loss drug dependence

The pharmaceutical sector's reliance on a handful of blockbuster drug cycles has rarely been more visible than in the weight-loss treatment boom. Novo Nordisk sits at the center of that boo

By Adaeze Nwosu·August 6, 2026·二〇二六年八月六日·2 min read

Source · 來源

ft.com

Share · 分享

X in f w

← Back to the News Desk Filed · Earnings

Related Dispatches

相關報導

News Desk →

01Earnings
Aflac's split quarter: net earnings up 37.7%, adjusted earnings down 7.7% as yen weighs
The yen averaged 159.45 to the dollar in the second quarter, 9.3% weaker than a year earlier, and for cross-border supplemental…
September 19, 2026 · 2 min
02Earnings
Technology's reset makes the sector a relative buy, Truist says
A sideways equity market running alongside rising earnings has opened a buying opportunity in technol
September 18, 2026 · 2 min
03Earnings
King Charles labels Sussexes private citizens as royal experts split over status letter
Britain's monarchy has long struggled to contain the commercial pull of former senior royals. King Charles sharpened that…
September 18, 2026 · 2 min

Elsewhere on the Desk

All Dispatches →

World

Trump-Greenland security pact draws Alaska comparison as Arctic competition narrows

September 19, 2026 · 2 min

Crypto加密

VanEck says Metaplanet executive equity still outpaces peers despite 41% share pool cut

September 19, 2026 · 2 min

Tech

Rate-hiking fears and AI safety debate put equity markets to the test

September 19, 2026 · 2 min

Crypto加密

Dario Amodei calls for embedded AI watchdogs as the frontier safety debate sharpens

September 19, 2026 · 2 min